Orphanet: Simple search
x

Search for a clinical trial

* (*) mandatory field

201 Result(s)

Sort by

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member = ; Member of a ERN =

National clinical trial(s)

CANADA

Ontario
TORONTO

FRANCE

GRAND-EST
VANDOEUVRE-LÈS-NANCY

Recruiting trial
Ongoing trial
NOVASED: Efficiency Clinical Study of NOVATEX MEDICAL Compression Garments in Patients With Ehlers-Danlos Syndrome.
CHU de Nancy - Hôpitaux de Brabois
Service de médecine interne et immunologie clinique

GERMANY

Baden-Württemberg
FREIBURG

Recruiting trial
Ongoing trial
ABASARC: Safety and efficacy of Abatacept in patients with treatment-resistant sarcoidosis
Klinik für Pneumologie am Universitätsklinikum Freiburg
Klinik für Pneumologie

UNITED KINGDOM

Humberside
COTTINGHAM

Recruiting trial
Ongoing trial
Azithromycin a Treatment for Pulmonary Sarcoidosis (CAPS)
Hull York Medical School
Respiratory Medicine Clinical Trials Unit

UNITED KINGDOM

Norfolk
NORWICH

AUSTRIA

WIEN
ADDRESS: NOT PROVIDED - AT

FRANCE

ILE-DE-FRANCE
PARIS

Recruiting trial
Ongoing trial
MSC: Treatment of Refractory Severe Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem Cells - (Phase I-II) - FR
CHU Paris-GH St-Louis Lariboisière F.Widal - Hôpital Saint-Louis
Unité de Médecine interne, Maladies Auto-immunes et Pathologie Vasculaire

FRANCE

ILE-DE-FRANCE
PARIS

Ongoing trial
Funded by an IRDiRC memberMSC-LES: Treatment of severe refractory systemic lupus erythematosus by injection of allogeneic mesenchymal stem cells derived from the umbilical cord
CHU Paris-GH St-Louis Lariboisière F.Widal - Hôpital Saint-Louis
Unité de Médecine interne, Maladies Auto-immunes et Pathologie Vasculaire

FRANCE

NOUVELLE AQUITAINE
LIMOGES

Ongoing trial
AmyDara: A Multicentre Open Label Phase II Study of Daratumumab in AL Amyloidosis Patients Not in VGPR or Better - FR
CHU de Limoges - Hôpital Dupuytren
Service d'hématologie clinique et de thérapie cellulaire

GERMANY

Baden-Württemberg
HEIDELBERG

GERMANY

Baden-Württemberg
HEIDELBERG

Ongoing trial
An open-label, phase 1/2 study of melflufen and dexamethasone for patients with al amyloidosis following at least one prior line of therapy - DE
Zentrum für Innere Medizin (Krehl-Klinik)
Abteilung Innere Medizin V - Hämatologie, Onkologie und Rheumatologie

ITALY

LOMBARDIA
PAVIA

Recruiting trial
Ongoing trial
Funded by an IRDiRC memberEffect of losartan vs. nebivolol vs. the association of both on the progression of aortic root dilatation in patients with Marfan syndrome mutation carriers of the gene FBN1
Fondazione IRCCS Policlinico San Matteo
Laboratorio di Diagnostica Molecolare, Patologia Cardiovascolare e dei Trapianti

ITALY

TOSCANA
FIRENZE

Ongoing trial
Randomized Controlled Trial for Testing the Efficacy of Well-Being Therapy in Patients With Systemic Sclerosis
Università degli studi di Firenze
Dipartimento di Scienze della Salute

NETHERLANDS

Utrecht
UTRECHT

PORTUGAL

NORTE
PORTO

Recruiting trial
Ongoing trial
Trial to Evaluate Safety and Tolerability of ALN-TTR01 in Transthyretin (TTR) Amyloidosis (Phase I)
Hospital de Santo António - Centro Hospitalar do Porto
Unidade Clínica de Paramiloidose

PORTUGAL

NORTE
PORTO

Ongoing trial
Open-Label Safety and Efficacy Evaluation of Fx-1006A in Patients With Transthyretin Amyloidosis (Phase II/III)
Hospital de Santo António - Centro Hospitalar do Porto
Unidade Clínica de Paramiloidose

PORTUGAL

SUL
LISBOA

Ongoing trial
Open-Label Safety and Efficacy Evaluation of Fx-1006A in Patients With Transthyretin Amyloidosis (Phase II/III)
Hospital de Sta. Maria - Centro Hospitalar de Lisboa Norte, EPE.
Serviço de Neurologia

UNITED KINGDOM

Greater London
LONDON

Ongoing trial
A randomized open-label multicenter phase III trial of Melphalan and Dexamethasone (MDex) versus Bortezomib, Melphalan and Dexamethasone (BMDex) for untreated patients with systemic light-chain (AL) amyloidosis - UK
Joint UCLH/UCL Biomedical Research and Development (R&D) Unit
University College London (UCL) and University College London Hospitals NHS Trust (UCLH)

BELGIUM

OOST-VLAANDEREN
GENT

Recruiting trial
Ongoing trial
NOVESA studie: GLPG1690 in de behandeling van vroegtijdige diffuse systeemsclerose - BE
Ghent University Hospital - UZ Gent
Department of Rheumatology

GERMANY

Baden-Württemberg
TÜBINGEN

Recruiting trial
Ongoing trial
AST-MOMA: Highdose Chemotherapy and transplantation of CD34 selected stem cell for progressive systemic sclerosis - Modification according to manifestation (Phase II)
Interdisziplinäres Rheumazentrum (INDIRA)
Zentrum für Interdisziplinäre Rheumatologie, klinische Immunologie und Autoimmunerkrankungen

GERMANY

Bayern
ERLANGEN

Ongoing trial
RESOLVE-1: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis -DE-
Internistisches Zentrum des Universitätsklinikums Erlangen
Medizinische Klinik 3 - Rheumatologie und Immunologie

GERMANY

Berlin
BERLIN

Ongoing trial
RESOLVE-1: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis -DE-
Charité - Universitätsmedizin Berlin (CCM)
Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie

HUNGARY

Közép-Magyarország
BUDAPEST

ITALY

LIGURIA
GENOVA

Ongoing trial
Five-year actively controlled clinical trial in new onset juvenile dermatomyositis
IRCCS Istituto G. Gaslini - Ospedale Pediatrico
U.O. Pediatria II

UNITED KINGDOM

Derbyshire
CHESTERFIELD

UNITED KINGDOM

Greater London
LONDON

UNITED KINGDOM

Greater London
LONDON

UNITED KINGDOM

Greater London
LONDON

Recruiting trial
Ongoing trial
Funded by an IRDiRC memberPhase II Study of Arimoclomol for the Treatment of Sporadic Inclusion Body Myositis (IBM) - GB
UCL Institute of Neurology, University College London,
Clinical Neurosciences

UNITED KINGDOM

Greater London
LONDON

UNITED KINGDOM

Greater London
LONDON

Ongoing trial
RESOLVE-1: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis-GB
University College London Medical School and Royal Free Hospital
Metabolic Bone Disease - Centre for Rheumatology and Connective Tissue Diseases

Multinational clinical trial(s)

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US